Investors' focus will likely be on GILD's HIV franchise performance and oncology sales when the company reports fourth-quarter 2024 results.

Gilead Sciences to Report Q4 Earnings: Is a Beat in the Cards?

Gilead Sciences (GILD) closed at $99.65 in the latest trading session, marking a +1.69% move from the prior day.

Gilead Sciences (GILD) Surpasses Market Returns: Some Facts Worth Knowing

Gilead (GILD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Gilead Sciences (GILD) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Gilead (GILD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock

The latest trading day saw Gilead Sciences (GILD) settling at $92.96, representing a +1.22% change from its previous close.

Why Gilead Sciences (GILD) Outpaced the Stock Market Today

In a report released yesterday, Tyler Van Buren from TD Cowen maintained a Buy rating on Gilead Sciences (GILD – Research Report), with a ...

Gilead Sciences: Strong Financial Performance and Promising Outlook Underpin Buy Rating | Markets Insider

The Speculation Around an AstraZeneca-Gilead Merger AstraZeneca, the UK’s largest drugmaker valued at $140bn, has reportedly contacted Gilead Sciences, an American biopharmaceutical company with a market value of approximately $96bn, regarding a possible merger deal.

AstraZeneca and Gilead Sciences merger would be the biggest in the pharma history

Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors. Gilead Sciences, Verizon Communications and ManpowerGroup have rewarded their shareholders for several decades and recently ...

Gilead Sciences, Verizon Communications And ManpowerGroup Are Winners For Passive Income

Gilead Sciences

A list with 17 of the highest paying cities for Software Engineers in the San Francisco Bay Area. Curate by reports from the verified professionals at Blind.

17 Highest-Paying Cities in the San Francisco Bay Area for Software Engineers

Artificial Intelligence & Deep Learning for Medical Diagnosis

Last December, stories started surfacing of a new virus affecting the Chinese city of Wuhan. At the epicenter of the outbreak, Chinese officials started building new hospitals to aid the people in need. What started out as something that looked like a flu epidemic, soon escalated into a full blown pandemic, called the novel coronavirus (SARS-CoV-2).

4 Potential Drug Treatment Options to Battle This Outbreak of Coronavirus

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company primary areas of focus include HIV, AIDS, liver disease, and serious cardiovascular and respiratory conditions.

GILEAD SCIENCES

gilead.com

employees

Since 1987

COMPANY RANKING

GILEAD SCIENCES

EVERGREEN INDEX #1762

Representing this company? Click here to claim and customize this page!

Read More Tech Stories Related to #Gilead Sciences

Gilead Sciences WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!

Categories

Trending Topics

GILEAD SCIENCES

gilead.com

employees

Since 1987

COMPANY RANKING

GILEAD SCIENCES

EVERGREEN INDEX #1762

RELATED COMPANIESRANK

HACKERNOON STORIES ON GILEAD SCIENCES

Representing this company? Click here to claim and customize this page!

Read More Tech Stories Related to #Gilead Sciences

Gilead Sciences WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!

Categories

Trending Topics